Selecta Biosciences, Inc. (NASDAQ:SELB – Get Rating) has been assigned an average recommendation of “Buy” from the seven brokerages that are covering the stock, MarketBeat.com reports. Six equities research analysts have rated the stock with a buy recommendation. The average 1 year price objective among analysts that have issued a report on the stock in […]
Protein design to precision health: Vote for Health Innovation of the Year at the GeekWire Awards geekwire.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from geekwire.com Daily Mail and Mail on Sunday newspapers.
Selecta Biosciences (NASDAQ:SELB – Get Rating)‘s stock had its “buy” rating restated by equities research analysts at Needham & Company LLC in a note issued to investors on Thursday, Benzinga reports. They presently have a $5.00 target price on the stock. Needham & Company LLC’s price target would suggest a potential upside of 306.50% from […]
Needham & Company LLC restated their buy rating on shares of Selecta Biosciences (NASDAQ:SELB – Get Rating) in a research report released on Thursday, Benzinga reports. Needham & Company LLC currently has a $5.00 price target on the stock. SELB has been the topic of several other research reports. HC Wainwright increased their target price […]